Navigation Links
Pain Relief in Just One Visit with Genzyme's Synvisc-One
Date:3/23/2009

Single-injection products will drive the US Hyaluronic Acid Viscosupplementation market to nearly $1 billion by 2013, according to Millennium Research Group

WALTHAM, Mass., March 23 /PRNewswire/ -- According to Millennium Research Group's (MRG's) US Markets for Orthopedic Biomaterials 2009 report, the US launch of Genzyme Biosurgery's single-injection Synvisc-One will drive procedural growth in the hyaluronic acid (HA) viscosupplementation market. Released to the market in February 2009, Synvisc-One adoption will fuel HA viscosupplementation revenues to reach nearly $1 billion by 2013.

Prior to the launch, HA viscosupplementation treatments were available only in 3-and 5-injection regimens. Over the next several years, many physicians are expected to adopt single-injection products in place of the 3- and 5-injection treatments. Single-injection treatments, which offer greater convenience and less pain, will gain popularity among both patients and physicians over the next five years and will account for approximately one-third of treatments by 2013. With Synvisc-One currently the only approved single-injection treatment, Genzyme Biosurgery is positioned to benefit from this shift in preference.

"The HA viscosupplementation market is the fastest-growing segment of the orthopedic biomaterial market, fueled in particular by the rise of single-injection treatments," says Kevin Flewwelling, Manager of the Orthopedics division at MRG. "Now that Synvisc-One has approval in the US, the door is open for the release of other single-injection products that will be launched through to 2013, driving the high growth in this market."

In addition to HA viscosupplementation, MRG's US Markets for Orthopedic Biomaterials 2009 report covers bone graft substitutes, machined bone interbody devices, cell concentration systems, and knee cartilage repair. The report also provides coverage of all key i
'/>"/>

SOURCE Millennium Research Group
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Anesiva Initiates New Phase 2 Trial of Adlea(TM) for Pain Relief Following Knee Replacement Surgery
2. Anesiva Initiates Phase 2 Trial with Adlea(TM) for Pain Relief Following Total Hip Replacement Surgery
3. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
4. Cost-Effectiveness Study Supports Use of EUFLEXXA(TM) by Rheumatologists for Pain Relief in Patients with Knee Osteoarthritis
5. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
6. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
7. MitraClip Device Preliminary Data Suggests Improved Heart Function and Relief from Heart Failure Symptoms in Functional Mitral Regurgitation Patients
8. invivodata Captures Symptom Relief Data in Endometriosis Trial
9. CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
10. FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain
11. Study of Cannabinoid Medicine for Pain Found Patients Got High, but Effects Not Related to Pain Relief
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... BETHLEHEM, Pa. , Nov. 21, 2014 /PRNewswire/ ... drug eluting devices, has developed and manufactured a ... Institute (LPRI), the Research and Development arm of ... Vice President of Project Management at Particle Sciences, ... Particle Sciences utilizing our material sciences and modeling ...
(Date:11/22/2014)... , Nov. 21, 2014 Many ... Undoubtedly, the growing influence of patients in the ... marketing interactions. Now, more than ever, understanding how ... for medical products is essential. ... Practices, LLC, benchmarked companies spent about two-thirds of ...
(Date:11/21/2014)... COLLEGE PARK, Md. , Nov. 21, 2014 /PRNewswire-USNewswire/ ... Engineering today will host the ceremonial groundbreaking of the ... Maryland, College Park. The new building will cultivate transformative ... human health.  Taking place at 10:00 a.m. ... building in the Paint Branch Parking Lot, adjacent to ...
Breaking Medicine Technology:Particle Sciences' Clinical Trial Supplies Group Manufactures Innovative Vaginal Ring 2New Report Details Importance of Adopting a "Patient Journey" Framework in Marketing 2University of Maryland Breaks Ground for A. James Clark Hall 2University of Maryland Breaks Ground for A. James Clark Hall 3University of Maryland Breaks Ground for A. James Clark Hall 4
... October 25, 2011 International medical ... (NASDAQ OMX Stockholm: SECT B) , announces ... University Hospitals (UH) in Cleveland.   UH and ... medical imaging with the goals of improving patient care, ...
... SUNNYVALE, Calif., Oct. 25, 2011 ... premier radiation oncology company, today announced that the U.S. ... 510(k) clearance to market the Dose Control System (DCS), ... system performance.   The TomoTherapy System revolutionized ...
Cached Medicine Technology:Sectra Signs Medical Imaging Research Agreement With University Hospitals in Cleveland 2Sectra Signs Medical Imaging Research Agreement With University Hospitals in Cleveland 3Accuray Receives 510(k) Clearance for a Rotational Dose Control for the TomoTherapy System 2Accuray Receives 510(k) Clearance for a Rotational Dose Control for the TomoTherapy System 3
(Date:11/22/2014)... Discount-Dress.com is an important company in the dress industry. ... company’s online market share by a series of promotions. Recently, ... announced a bridesmaid dress promotion for the new year 2015. ... the dresses from this company are not only of high ... very good at manufacturing wedding dresses. Customers prefer to choose ...
(Date:11/22/2014)... 2014 Domestic farmgate milk and ... 2009-10, due to a fall in demand for ... products amid the global financial crisis. However, these ... Australian dairy manufacturers on the international scene. Strong ... supply growth, primarily due to supply constraints in ...
(Date:11/22/2014)... November 22, 2014 Hastings and Hastings, ... of experience announces providing clients with the option of ... offers clients a flexible, intuitive and easy to navigate ... having access to Google + allows clients to research ... make a more informed decision when retaining an attorney. ...
(Date:11/22/2014)... A new technology for airport ... safely detects and identifies hazards inside and outside ... by RHT SpectraSafe, the technology avoids hazardous x-rays ... other areas including medical, recycling, military, and food ... frequency radio waves that pass harmlessly through the ...
(Date:11/22/2014)... Nov. 21, 2014 (HealthDay News) -- A clinical trial ... has been halted a year early because the results ... manage the disease and reduce the risk of stroke. ... at 25 medical centers in the United States and ... Heart, Lung, and Blood Institute (NHLBI). Researchers compared ...
Breaking Medicine News(10 mins):Health News:Bridesmaid Dresses Introduced by Famous Company Discount-Dress.com For The New Year 2015 2Health News:Butter and Dairy Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Butter and Dairy Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Butter and Dairy Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:Hastings and Hastings Announces Providing Clients with the Option of Leaving an Online Review Using Google + 2Health News:Hastings and Hastings Announces Providing Clients with the Option of Leaving an Online Review Using Google + 3Health News:RHT SpectraSafe announces a Radical New Airport Security Technology that Is More Effective, Less Invasive 2Health News:Sickle Cell Anemia Treatment So Successful in Kids That Trial Is Halted 2
... premier educational gathering of the world,s leading laser experts hosted by ... ... Wausau, WI (PRWEB) November 20, 2008 -- The American Society ... National Harbor, Md., April 1 - 5, 2009     , , ...
... California reorganization plans , , ... this week in an advisory vote on two reorganization plans. ... whether they want to be part of a new single ... representing a broader classification of healthcare workers. , ...
... cancer survival are largely inaccurate because they widely disregard ... in addition to their primary cancer, says Jay Piccirillo, ... School of Medicine in St. Louis, the Siteman Cancer ... problem with cancer survival statistics, which generally don,t take ...
... Cyberonics, Inc. (Nasdaq: CYBX ),today announced results for the quarter ... , Results for the second quarter of ... , -- Net sales of $36.0 million, a 24% increase ... the epilepsy indication, increased by an estimated ...
... and slows the progression of AIDS, study confirms , , ... finalizes research that changed guidelines around the world regarding ... on preliminary findings released last year, several health agencies ... begin HIV treatment early in babies, instead of waiting ...
... congressional breakfast briefing on the subject of civic engagement ... as the closing session of the 61st Annual Scientific ... President-Elect Barack Obama has voiced support for an expanded ... are preparing to work quickly with congressional leaders to ...
Cached Medicine News:Health News:Announcing a Monumental Sharing of Laser Innovation: The American Society for Laser Medicine and Surgery (ASLMS) Holds 29th Annual Conference in National Harbor, Md., April 1 - 5, 2009 2Health News:Advisory Vote Begins on California Long-Term Care Local 2Health News:Survival of head and neck cancer patients is greatly affected by coexisting ailments 2Health News:Survival of head and neck cancer patients is greatly affected by coexisting ailments 3Health News:Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter 2Health News:Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter 3Health News:Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter 4Health News:Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter 5Health News:Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter 6Health News:Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter 7Health News:Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter 8Health News:Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter 9Health News:Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter 10Health News:Early HIV Treatment Best for Babies 2
The Dolphin Medical 2150 Pulse Oximeter consists of the Dolphin ONE OEM 701 Module technology, (1) extension cable, and (1) oximetry sensor to non-invasively calculate the functional saturation of ar...
All-in-One Fingertip Oximeter...
... The Invacare Sleep Printing ... specifically designed to address ... a device that can ... conducting overnight screening for ...
The reliable and easy-to-use 3900/P pulse oximeter is now more advanced - featuring TruTrak+ technology, the proprietary clinical motion algorithm from Datex+-Ohmeda....
Medicine Products: